-
1. The freedom space – a new set of commercially available molecules for hit discovery
-
2. Development of a Potent and Selective G2A (GPR132) Agonist
-
3. Structure-based discovery of CFTR potentiators and inhibitors
-
4. AlphaFold2 structures guide prospective ligand discovery
-
5. Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography
-
6. Docking for EP4R antagonists active against inflammatory pain
-
7. The challenge of balancing model sensitivity and robustness in predicting yields: a benchmarking study of amide coupling reactions
-
8. AI-Powered Virtual Screening of Large Compound Libraries Leads to the Discovery of Novel Inhibitors of Sirtuin-1
-
9. Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors
-
10. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes
-
11. Computer-Aided Design Of Muscarinic Acetylcholine Receptor M3 Inhibitors: Promising Compounds Among Trifluoromethyl Containing Hexahydropyrimidinones/Thiones
-
12. Discovery, Synthesis, and In Vitro Characterization of 2,3 Derivatives of 4,5,6,7-Tetrahydro-Benzothiophene as Potent Modulators of Retinoic Acid Receptor-Related Orphan Receptor γt
-
13. ZINC-22─A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery
-
14. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
-
15. Challenges for chemistry in Ukraine after the war: Ukrainian science requires rebuilding and support
-
16. C−C Coupling through Nitrogen Deletion: Application to Library Synthesis
-
17. Advancing molecular graphs with descriptors for the prediction of chemical reaction yields
-
18. Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds
-
19. Magnet for the Needle in Haystack: “Crystal Structure First” Fragment Hits Unlock Active Chemical Matter Using Targeted Exploration of Vast Chemical Spaces
-
20. Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor
-
21. The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd
-
22. In Vitro and In Silico Evaluation of Cholinesterase Inhibition by Alkaloids Obtained from Branches of Abuta panurensis Eichler
-
23. Creation of targeted compound libraries based on 3D shape recognition
-
24. Virtual Screening in Search for a Chemical Probe for Angiotensin-Converting Enzyme 2 (ACE2)
-
25. A Close-up Look at the Chemical Space of Commercially Available Building Blocks for Medicinal Chemistry
-
26. Structures of the σ2 receptor enable docking for bioactive ligand discovery
-
27. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
-
28. SynthI: A New Open-Source Tool for Synthon-Based Library Design
-
29. Scalable Approach to Fluorinated Heterocycles with Sulfur Tetrafluoride (SF4)
-
30. One-pot parallel synthesis of 1,3,5-trisubstituted 1,2,4-triazoles
-
31. Synthesis of α-substituted 2-(1H-1,2,4-triazol-3-yl)acetates and 5-amino-2,4-dihydro-3H-pyrazol-3-ones via the Pinner strategy
-
32. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
-
33. Generating Multibillion Chemical Space of Readily Accessible Screening Compounds
-
34. SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules
-
35. ZINC20—A Free Ultralarge-Scale Chemical Database for Ligand Discovery
-
37. Synthesis, biological evaluation, and modeling studies of 1,3-disubstituted cyclobutane-containing analogs of combretastatin A4
-
38. Synthesis of Spirocyclic β‐ and γ‐Sultams by One‐Pot Reductive Cyclization of Cyanoalkylsulfonyl Fluorides
-
39. Multigram Synthesis of Advanced 6,6-Difluorospiro[3.3]heptane-Derived Building Blocks
-
40. An open-source drug discovery platform enables ultra-large virtual screens
-
41. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
-
42. Sulfonimidamides and Imidosulfuric Diamides: Compounds from an Underexplored Part of Biologically Relevant Chemical Space
-
43. (Het)aryl Difluoromethyl-Substituted β-Alkoxyenones: Synthesis and Heterocyclizations
-
44. Synthesis of 5-(Fluoroalkyl)isoxazole Building Blocks by Regioselective Reactions of Functionalized Halogenoximes
-
45. Regioselective Synthesis of Functionalized 3- or 5-Fluoroalkyl Isoxazoles and Pyrazoles from Fluoroalkyl Ynones and Binucleophiles
-
46. One-Pot Parallel Synthesis of 5-(Dialkylamino)tetrazoles
-
47. SAR by Space: Enriching Hit Sets from the Chemical Space
-
48. Pros and cons of virtual screening based on public ‘Big Data’: In silico mining for new bromodomain inhibitors
-
49. Ultra-large library docking for discovering new chemotypes
-
50. Evolution of commercially available compounds for HTS
-
51. (Chlorosulfonyl)benzenesulfonyl Fluorides—Versatile Building Blocks for Combinatorial Chemistry: Design, Synthesis and Evaluation of a Covalent Inhibitor Library
-
52. Facile One-Pot Parallel Synthesis of 3-Amino-1,2,4-triazoles
-
53. Saturated Heterocyclic Aminosulfonyl Fluorides: New Scaffolds for Protecting-Group-Free Synthesis of Sulfonamides
-
1. An algorithmic framework for synthetic cost-aware decision making in molecular design
-
2. Enhanced Calculation of Property Distributions in Chemical Fragment Spaces
-
3. Navigating large chemical spaces in early-phase drug discovery
-
4. Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses
-
5. Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration
-
6. Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining
-
7. Degradation Characteristics of a Novel PAF Receptor Antagonist, SY0916, in Aqueous Solution
